Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

This article is part of the supplement: Proceedings of the 8th Global Arthritis Research Network (GARN) Meeting and 1st Bio-Rheumatology International Congress (BRIC)

Poster presentation

GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded end point (PROBE) trial

Byron Cryer*, Chunming Li, Lee S Simon, Gurkirpal Singh, Martin J Stillman and Manuela Berger

  • * Corresponding author: Byron Cryer

Arthritis Research & Therapy 2012, 14(Suppl 1):P63  doi:10.1186/ar3664

No comments have yet been made on this article.

Post a comment